Mikaël Daouphars

832 total citations
23 papers, 626 citations indexed

About

Mikaël Daouphars is a scholar working on Occupational Therapy, Oncology and Geriatrics and Gerontology. According to data from OpenAlex, Mikaël Daouphars has authored 23 papers receiving a total of 626 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Occupational Therapy, 6 papers in Oncology and 5 papers in Geriatrics and Gerontology. Recurrent topics in Mikaël Daouphars's work include Safe Handling of Antineoplastic Drugs (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Cancer Treatment and Pharmacology (3 papers). Mikaël Daouphars is often cited by papers focused on Safe Handling of Antineoplastic Drugs (6 papers), Pharmaceutical Practices and Patient Outcomes (5 papers) and Cancer Treatment and Pharmacology (3 papers). Mikaël Daouphars collaborates with scholars based in France, Germany and Netherlands. Mikaël Daouphars's co-authors include Jean‐Baptiste Rey, Vincent Launay‐Vacher, Corinne Isnard Bagnis, Gilbert Deray, A. Astier, Frédéric Pinguet, Rainer Trittler, Jean Vigneron, Christophe Bardin and Arnold G. Vulto and has published in prestigious journals such as Cancer Treatment Reviews, Value in Health and Cancer Chemotherapy and Pharmacology.

In The Last Decade

Mikaël Daouphars

22 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mikaël Daouphars France 10 183 157 134 107 95 23 626
Vérane Schwiertz France 14 103 0.6× 42 0.3× 64 0.5× 151 1.4× 32 0.3× 31 607
Nicolas Vantard France 14 104 0.6× 37 0.2× 67 0.5× 134 1.3× 20 0.2× 29 591
Raymond J. Muller United States 10 233 1.3× 16 0.1× 110 0.8× 163 1.5× 24 0.3× 20 822
Peter J Gilbar Australia 14 115 0.6× 22 0.1× 49 0.4× 190 1.8× 28 0.3× 61 579
B. Gourieux France 12 78 0.4× 18 0.1× 20 0.1× 113 1.1× 64 0.7× 58 503
Ahmed O. Almobarak Sudan 17 30 0.2× 80 0.5× 63 0.5× 32 0.3× 44 0.5× 40 806
Elaine Lennan United Kingdom 10 77 0.4× 9 0.1× 38 0.3× 188 1.8× 59 0.6× 25 473
Sylvia Bartel United States 13 205 1.1× 5 0.0× 128 1.0× 208 1.9× 94 1.0× 20 767
Synnöve Lindemalm Sweden 15 211 1.2× 28 0.2× 7 0.1× 39 0.4× 63 0.7× 32 507
Jane M. Pruemer United States 10 57 0.3× 10 0.1× 38 0.3× 91 0.9× 37 0.4× 22 353

Countries citing papers authored by Mikaël Daouphars

Since Specialization
Citations

This map shows the geographic impact of Mikaël Daouphars's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mikaël Daouphars with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mikaël Daouphars more than expected).

Fields of papers citing papers by Mikaël Daouphars

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mikaël Daouphars. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mikaël Daouphars. The network helps show where Mikaël Daouphars may publish in the future.

Co-authorship network of co-authors of Mikaël Daouphars

This figure shows the co-authorship network connecting the top 25 collaborators of Mikaël Daouphars. A scholar is included among the top collaborators of Mikaël Daouphars based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mikaël Daouphars. Mikaël Daouphars is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Daouphars, Mikaël, et al.. (2021). Évaluation d’une salle de naissance des erreurs virtuelle en formation initiale. Sages-Femmes. 20(2). 47–52. 1 indexed citations
3.
Slimano, Florian, Jérémie Zerbit, Audrey Thomas‐Schoemann, et al.. (2020). Cancer, immune suppression and Coronavirus Disease-19 (COVID-19): Need to manage drug safety (French Society for Oncology Pharmacy [SFPO] guidelines). Cancer Treatment Reviews. 88. 102063–102063. 33 indexed citations
4.
5.
Duclos, Martine, et al.. (2017). Port Catheter Versus Peripherally Inserted Central Catheter For Adjuvant Chemotherapy In Breast Cancer: A Cost-Effectiveness Analysis. Value in Health. 20(9). A583–A583. 2 indexed citations
6.
Daouphars, Mikaël, et al.. (2016). Physicochemical stability of oxycodone-ketamine solutions in polypropylene syringe and polyvinyl chloride bag for patient-controlled analgesia use. European Journal of Hospital Pharmacy. 25(4). 214–217. 7 indexed citations
7.
Giraud, Sophie, C. Capet, I. Landrin, et al.. (2015). Impact of recommendations on crushing medications in geriatrics: from prescription to administration. Fundamental and Clinical Pharmacology. 29(3). 316–320. 36 indexed citations
8.
Madelaine, Isabelle, Jean‐François Tournamille, Agnès Bellanger, et al.. (2014). Étude impacto : analyse descriptive des pratiques de pharmacie clinique en cancérologie. Annales Pharmaceutiques Françaises. 73(3). 223–228. 8 indexed citations
9.
Vigneron, Jean, A. Astier, Rainer Trittler, et al.. (2013). SFPO and ESOP recommendations for the practical stability of anticancer drugs: An update. Annales Pharmaceutiques Françaises. 71(6). 376–389. 30 indexed citations
10.
Daouphars, Mikaël, et al.. (2013). Preliminary Validation of Self‐assessment Tool to Measure Imatinib Adherence in Patients with Chronic Myeloid Leukemia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 33(2). 152–156. 16 indexed citations
11.
Daouphars, Mikaël, et al.. (2012). L’arrêt de commercialisation des médicaments contenant du dextropropoxyphène : quelles conséquences sur les prescriptions d’antalgiques ?. Journal de Pharmacie Clinique. 31(1). 11–25. 1 indexed citations
12.
Daouphars, Mikaël, et al.. (2012). Knowledge Assessment and Information Needs of Oncology Nurses Regarding Inpatient Medication. Clinical journal of oncology nursing. 16(2). 182–187. 7 indexed citations
13.
Astier, A., Arnold G. Vulto, Rainer Trittler, et al.. (2012). Guidelines for the practical stability studies of anticancer drugs: a European consensus conference: Table 1. European Journal of Hospital Pharmacy. 19(3). 278–285. 14 indexed citations
14.
Goodin, Susan, et al.. (2011). Safe Handling of Oral Chemotherapeutic Agents in Clinical Practice: Recommendations From an International Pharmacy Panel. Journal of Oncology Practice. 7(1). 7–12. 79 indexed citations
15.
Bardin, Christophe, A. Astier, Arnold G. Vulto, et al.. (2011). Guidelines for the practical stability studies of anticancer drugs: A European consensus conference. Annales Pharmaceutiques Françaises. 69(4). 221–231. 131 indexed citations
16.
Lévesque, H., Mikaël Daouphars, Véronique Le Cam‐Duchez, et al.. (2009). Facteurs de risque de surdosage en antivitamines K : une étude cas-témoins menée chez des patients non sélectionnés admis dans un service d'urgences. Journal de Pharmacie Clinique. 28(2). 73–81. 1 indexed citations
17.
Launay‐Vacher, Vincent, Jean‐Baptiste Rey, Corinne Isnard Bagnis, Gilbert Deray, & Mikaël Daouphars. (2008). Prevention of cisplatin nephrotoxicity: state of the art and recommendations from the European Society of Clinical Pharmacy Special Interest Group on Cancer Care. Cancer Chemotherapy and Pharmacology. 61(6). 903–909. 216 indexed citations
18.
19.
Jouzeau, Jean‐Yves, Mikaël Daouphars, Alexandre Bénani, & Patrick Netter. (2004). Pharmacologie et classification des inhibiteurs de la cyclooxygénase. Gastroentérologie Clinique et Biologique. 28. 7–17. 3 indexed citations
20.
Jouzeau, Jean‐Yves, Mikaël Daouphars, & Patrick Netter. (2004). Place des coxibs dans l’arsenal thérapeutique : quelques certitudes et beaucoup de doutes. Therapies. 59(2). 207–211. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vérane Schwiertz Breakdown of academic impact, for papers by Nicolas Vantard Breakdown of academic impact, for papers by Raymond J. Muller Breakdown of academic impact, for papers by Peter J Gilbar Breakdown of academic impact, for papers by B. Gourieux Breakdown of academic impact, for papers by Ahmed O. Almobarak Breakdown of academic impact, for papers by Elaine Lennan Breakdown of academic impact, for papers by Sylvia Bartel Breakdown of academic impact, for papers by Synnöve Lindemalm Breakdown of academic impact, for papers by Jane M. Pruemer
Rankless by CCL
2026